Organisation paid for research Program year 2025 Source: CMS Open Payments

Perceptive Pharma Research LLC

Neither a doctor nor a teaching hospital

Research payments

$872,663

146 payments

Through program year 2025, Perceptive Pharma Research LLC is reported as receiving $872,663 in research payments, across 146 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$252,724	23
2024	Research	$81,158	12
2023	Research	$11,661	4
2022	Research	$68,820	8
2021	Research	$53,715	16
2020	Research	$179,047	44
2019	Research	$225,537	39

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $671,877 138 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $185,586 6 payments
Intercept Pharmaceuticals, Inc. $10,200 1 payment
Neurocrine Biosciences, Inc. $5,000 1 payment

Studies the money was for Research payments · program years 2019–2025

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder (CANTO) $184,096 9 payments
Adjunctive Computerized Cognitive Training CCT $157,214 4 payments
M14-234 $70,130 17 payments
M15-991 $63,094 12 payments
M14-675 $57,009 10 payments
M14-430 $47,386 15 payments
A Study of the Change in Disease State and Safety of Oral Cariprazine Capsules in the Treatment of Depression in Pediatric Participants (10 to 17 Years of Age) With Bipolar I Disorder $37,260 6 payments
M16-000 $26,973 13 payments
M16-006 $22,031 5 payments
PoC in Prevention of Relapse $16,920 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.